Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Sachewsky

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomedicines|March 28, 2024
Ectopic Expression of Neurod1 Is Sufficient for Functional Recovery following a Sensory-Motor Cortical StrokeJessica M Livingston, Tina T Lee, Tom Enbar, et al.
Cell Stem Cell|November 12, 2013
Transient maternal IL-6 mediates long-lasting changes in neural stem cell pools by deregulating an endogenous self-renewal pathwayDenis Gallagher, Andreea A Norman, Cameron L Woodard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 24, 2025
Cell therapy with human Interleukin 10-producing ILC2s enhances islet function and inhibits allograft rejectionSarah J Colpitts, Sinthuja Jegatheeswaran, Amanda Oakie, et al.
Cell Reports|December 25, 2024
Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responsesKyle T Reid, Sarah J Colpitts, Jessica A Mathews, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomedicines|March 28, 2024
Ectopic Expression of Neurod1 Is Sufficient for Functional Recovery following a Sensory-Motor Cortical StrokeJessica M Livingston, Tina T Lee, Tom Enbar, et al.
Cell Stem Cell|November 12, 2013
Transient maternal IL-6 mediates long-lasting changes in neural stem cell pools by deregulating an endogenous self-renewal pathwayDenis Gallagher, Andreea A Norman, Cameron L Woodard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 24, 2025
Cell therapy with human Interleukin 10-producing ILC2s enhances islet function and inhibits allograft rejectionSarah J Colpitts, Sinthuja Jegatheeswaran, Amanda Oakie, et al.
Cell Reports|December 25, 2024
Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responsesKyle T Reid, Sarah J Colpitts, Jessica A Mathews, et al.
Pageof 2